In addition, serum PD-L1 was significantly elevated in patients with aggressive SM (ASM), SM with an associated hematologic neoplasm (SM-AHN), and mast cell leukemia (MCL), compared to patients with a non-advanced disease [15]. Here, CD274 is linked to systemic mastocytosis.